1
2
den Otter, A. A.S., van der Houwen, T. B., van Hagen, P. M., van Laar, J. A.M.
Veröffentlicht in: den Otter , A A S , van der Houwen , T B , van Hagen , P M & van Laar , J A M 2022 , ' Clinical course of COVID-19 infections in patients with Behçet’s disease in The Netherlands ' , Clinical and Experimental Rheumatology , vol. 40 , no. 8 , pp. 1504-1509 . https://doi.org/10.55563/clinexprheumatol/xdx09v;
2022
Veröffentlicht in: den Otter , A A S , van der Houwen , T B , van Hagen , P M & van Laar , J A M 2022 , ' Clinical course of COVID-19 infections in patients with Behçet’s disease in The Netherlands ' , Clinical and Experimental Rheumatology , vol. 40 , no. 8 , pp. 1504-1509 . https://doi.org/10.55563/clinexprheumatol/xdx09v;
2022
3
van Laar, S. A., Gombert-Handoko, K. B., Groenwold, R. H.H., van der Hulle, T., Visser, L. E., Houtsma, D., Guchelaar, H. J., Zwaveling, J.
Veröffentlicht in: van Laar , S A , Gombert-Handoko , K B , Groenwold , R H H , van der Hulle , T , Visser , L E , Houtsma , D , Guchelaar , H J & Zwaveling , J 2022 , ' Real-World Metastatic Renal Cell Carcinoma Treatment Patterns and Clinical Outcomes in The Netherlands ' , Frontiers in Pharmacology , vol. 13 , 803935 . https://doi.org/10.3389/fphar.2022.803935;
2022
Veröffentlicht in: van Laar , S A , Gombert-Handoko , K B , Groenwold , R H H , van der Hulle , T , Visser , L E , Houtsma , D , Guchelaar , H J & Zwaveling , J 2022 , ' Real-World Metastatic Renal Cell Carcinoma Treatment Patterns and Clinical Outcomes in The Netherlands ' , Frontiers in Pharmacology , vol. 13 , 803935 . https://doi.org/10.3389/fphar.2022.803935;
2022
4
van der Groef, Romy, de Jong, Pascal H.P., Hijnen, Dirk Jan, van der Woude, Christien J., van Laar, Jan A.M., van der Kuy, P. Hugo M., Brugma, Jan Dietert, Pasma, Annelieke
Veröffentlicht in: van der Groef , R , de Jong , P H P , Hijnen , D J , van der Woude , C J , van Laar , J A M , van der Kuy , P H M , Brugma , J D & Pasma , A 2023 , ' Impact of the First SARS-CoV-2 Lockdown on Adherence to Biological Treatment in Patients with Immune-Mediated Inflammatory Diseases in the Netherlands ' , Patient Preference and Adherence , vol. 17 , pp. 167-174 . https://doi.org/10.2147/PPA.S392290;
2023
Veröffentlicht in: van der Groef , R , de Jong , P H P , Hijnen , D J , van der Woude , C J , van Laar , J A M , van der Kuy , P H M , Brugma , J D & Pasma , A 2023 , ' Impact of the First SARS-CoV-2 Lockdown on Adherence to Biological Treatment in Patients with Immune-Mediated Inflammatory Diseases in the Netherlands ' , Patient Preference and Adherence , vol. 17 , pp. 167-174 . https://doi.org/10.2147/PPA.S392290;
2023
5
van der Houwen, Tim B., van Laar, Jan A.M., Kappen, Jasper H., van Hagen, Petrus M., de Zoete, Marcel R., van Muijlwijk, Guus H., Berbers, Roos Marijn, Fluit, Ad C., Rogers, Malbert, Groot, James, Hazelbag, C. Marijn, Consolandi, Clarissa, Severgnini, Marco, Peano, Clelia, D'Elios, Mario M., Emmi, Giacomo, Leavis, Helen L.
2020
2020